Search research articles
Contact Us
Filters
Showing results (41-50 of 188) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Case Report: response to ipilimumab in a patient with HIV with metastatic melanoma
Matthew M Burke, Harriet M Kluger, Marjorie Golden, et al.
Clinical Chemistry
|
May 19, 2017
The Phoenix Rises: The Rebirth of Cancer Immunotherapy
Ivan M Blasutig, Sofia Farkona, Elizabeth I Buchbinder, et al.
Diabetes Care
|
March 26, 2015
Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy
Jing Hughes, Nalini Vudattu, Mario Sznol, et al.
Journal for Immunotherapy of Cancer
|
March 2, 2020
Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report
Catarina Pinto, Michael Bergmann, Daria Briukhovetska, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2004
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer
Yun Yen, Kim Margolin, James Doroshow, et al.
American Journal of Clinical Oncology
|
August 25, 2021
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases
Haruka Uezono, David Nam, Harriet M Kluger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2005
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer
Mary M McCarthy, Mario Sznol, Kyle A DiVito, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 6, 2008
Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer
Nicolas Acquavella, Harriet Kluger, John Rhee, et al.
Journal of Neurosurgery
|
June 19, 2012
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
Jonathan P S Knisely, James B Yu, Jaclyn Flanigan, et al.
Cancer
|
April 28, 2011
A phase 2 trial of dasatinib in advanced melanoma
Harriet M Kluger, Arkadiuz Z Dudek, Carrie McCann, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 188) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2011
Case Report: response to ipilimumab in a patient with HIV with metastatic melanoma
Matthew M Burke, Harriet M Kluger, Marjorie Golden, et al.
Clinical Chemistry
|
May 19, 2017
The Phoenix Rises: The Rebirth of Cancer Immunotherapy
Ivan M Blasutig, Sofia Farkona, Elizabeth I Buchbinder, et al.
Diabetes Care
|
March 26, 2015
Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy
Jing Hughes, Nalini Vudattu, Mario Sznol, et al.
Journal for Immunotherapy of Cancer
|
March 2, 2020
Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report
Catarina Pinto, Michael Bergmann, Daria Briukhovetska, et al.
Cancer Chemotherapy and Pharmacology
|
May 19, 2004
A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer
Yun Yen, Kim Margolin, James Doroshow, et al.
American Journal of Clinical Oncology
|
August 25, 2021
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases
Haruka Uezono, David Nam, Harriet M Kluger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 22, 2005
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer
Mary M McCarthy, Mario Sznol, Kyle A DiVito, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 6, 2008
Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell cancer
Nicolas Acquavella, Harriet Kluger, John Rhee, et al.
Journal of Neurosurgery
|
June 19, 2012
Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
Jonathan P S Knisely, James B Yu, Jaclyn Flanigan, et al.
Cancer
|
April 28, 2011
A phase 2 trial of dasatinib in advanced melanoma
Harriet M Kluger, Arkadiuz Z Dudek, Carrie McCann, et al.
Page
of 19